Table 2 Association between homocysteine and cardiometabolic multimorbidity in different models (Association of Plasma Homocysteine with Cardiometabolic Multimorbidity: a cross-sectional study in Northwest China, 2018–2020)

having at least 2 diseases

Hcy

1.008 (1.005, 1.011)

< 0.001

1.006 (1.002, 1.009)

0.001

1.005 (1.002, 1.009)

0.003

Quartiles

Q1

Reference

Reference

Reference

Q2

1.308 (1.153, 1.483)

< 0.001

1.178 (1.034, 1.342)

0.014

1.161 (1.018, 1.323)

0.026

Q3

1.406 (1.241, 1.592)

< 0.001

1.164 (1.022, 1.325)

0.022

1.132 (0.994, 1.290)

0.062

Q4

1.524 (1.348, 1.723)

< 0.001

1.236 (1.087, 1.406)

0.001

1.203 (1.056, 1.370)

0.005

having at least 3 diseases

Hcy

1.007 (0.999, 1.014)

0.067

1.003 (0.995, 1.012)

0.407

1.002 (0.994, 1.011)

0.582

Quartiles

Q1

Reference

Reference

Reference

Q2

1.355 (1.002, 1.831)

0.049

1.125 (0.829, 1.528)

0.449

1.101 (0.810, 1.495)

0.540

Q3

1.327 (0.981, 1.797)

0.067

0.979 (0.719, 1.334)

0.894

0.921 (0.674, 1.258)

0.605

Q4

1.492 (1.110, 2.006)

0.008

1.081 (0.797, 1.465)

0.618

1.020 (0.750, 1.387)

0.899